CNTA

Centessa Pharmaceuticals
CNTA

Overview Fund Activity

44 hedge funds and large institutions have $669M invested in Centessa Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 16 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.7%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
5
Increased
16
Reduced
13
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MVM
1
Medicxi Ventures Management
Jersey
$179M
2
BI
2
BVF Inc
California
$15.7M
3
OMC
3
OUP Management Company
Pennsylvania
$26.4M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$22.7M
5
KCM
5
Kynam Capital Management
New Jersey
$6M

Top Sellers

1
VA
1
VR Adviser
New York
$3.69M
2
DTC
2
Deep Track Capital
Connecticut
$0
3
EC
3
EcoR1 Capital
California
$4.08M
4
AAA
4
Affinity Asset Advisors
New York
$586K
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$8.14M
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
51
UBS Group
Switzerland
– -$6K -496 Closed
1 2
3